PLoS ONE (Jan 2014)

Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.

  • Sulggi A Lee,
  • Elizabeth Sinclair,
  • Hiroyu Hatano,
  • Priscilla Y Hsue,
  • Lorrie Epling,
  • Frederick M Hecht,
  • David R Bangsberg,
  • Jeffrey N Martin,
  • Joseph M McCune,
  • Steven G Deeks,
  • Peter W Hunt

DOI
https://doi.org/10.1371/journal.pone.0089444
Journal volume & issue
Vol. 9, no. 2
p. e89444

Abstract

Read online

BackgroundChronic antigenic stimulation by cytomegalovirus (CMV) is thought to increase "immunosenesence" of aging, characterized by accumulation of terminally differentiated CD28- CD8+ T cells and increased CD57, a marker of proliferative history. Whether chronic HIV infection causes similar effects is currently unclear.MethodsWe compared markers of CD8+ T cell differentiation (e.g., CD28, CD27, CCR7, CD45RA) and CD57 expression on CD28- CD8+ T cells in healthy HIV-uninfected adults with and without CMV infection and in both untreated and antiretroviral therapy (ART)-suppressed HIV-infected adults with asymptomatic CMV infection.ResultsCompared to HIV-uninfected adults without CMV (n=12), those with asymptomatic CMV infection (n=31) had a higher proportion of CD28-CD8+ T cells expressing CD57 (P=0.005). Older age was also associated with greater proportions of CD28-CD8+ T cells expressing CD57 (rho: 0.47, P=0.007). In contrast, untreated HIV-infected CMV+ participants (n=55) had much lower proportions of CD28- CD8+ cells expressing CD57 than HIV-uninfected CMV+ participants (PConclusionsUnlike CMV and aging, which are associated with terminal differentiation and proliferation of effector memory CD8+ T cells, HIV inhibits this process, expanding less well-differentiated CD28- CD8+ T cells and decreasing the proportion of CD28- CD8+ T cells that express CD57.